Filters

Anti-GPR102/TAAR8 (Polyclonal), ALEXA Fluor 594

Anti-GPR102/TAAR8 (Polyclonal), ALEXA Fluor 594 size: 100 microliters 489

Supplier BIOSS POLYCLONAL ANTIBODIES
Price 489
Size 100 microliters
Contact us Ask Component cell markers and DNA bp. markers are genetic markerser genes or DNA sequenceswith selection audit
TypeConjugated Primary Antibody
Conjugated with 594, ALEXA FLUOR®
Host organismRabbit (Oryctolagus cuniculus)
Target Protein/PeptideGPR102/TAAR8
SpecificityThis antibody reacts specifically with GPR102/TAAR8
ModificationNo modification has been applied to this antibody
Modification siteNone
ClonalityPolyclonal Antibody
ClonePolyclonal Antibodies
Concentration1ug per 1ul
Subcellular locationsExtracellular
Antigen SourceKLH conjugated synthetic peptide derived from human G protein coupled receptor 102
Gene IDN/A
Swiss ProtN/A
Applications IF(IHC-P), FCM
Applications with corresponding dilutions IF(IHC-P)(1:50-200), FCM(1:20-100)
Cross reactive species Mouse (Mus musculus), Rat (Rattus norvegicus), Human (Homo sapiens)
Cross Reactive Species details However, note that due to limited knowledge it is impossible to predict with 100% guarantee that the antibody does not corss react with any other species, No significant cross reactivity has been observed for this antibody for the tested species
Background information A family of G-protein coupled receptors referred to as trace-amine-associated receptors (TAAR) are activated by trace amines and are present in very low levels in mammalian tissue, TAAR proteins are potential targets for drugs of abuse, TaRs contain several structural features that are similar to the rhodopsin â, and attention deficit disorder, as well as neuropsychiatric disorders including schizophrenia, depression, including the positions of the seven transmembrane regions that provide common ligand-binding pockets as well as the short N- and C-terminal domains, such as amphetamine and MDMA, &circ, «, -adrenergic receptor superfamily, Trace amines are endogenous molecules structurally related to classical biogenic amines that are linked to psychiatric conditions
Purification methodPurified by Protein A
Storage 50% glycerol and 0, Store at 4°, 09% sodium azide, C for 12 months, Water buffered solution containing 100ug/ml BSA
Excitation emission590nm/617nm
Synonyms TA5 TAR5
Also known asGPR102/TAAR8 Polyclonal Antibody
Other nameAnti-GPR102/TAAR8 Polyclonal
Advisory For antibodies that are in liquid form or reconstituted lyophilized antibodies small amounts could become entrapped on the seal or the walls of the tube, Prior to use briefly centrifuge the vial to gather all the solution on the bottom, specificity and sensitivity, thus reducing its reactivity, Avoid freeze/thaw cycles as they may denaturate the polypeptide chains of the antibody
PropertiesFor facs or microscopy Alexa 1 conjugate
ConjugationAlexa Fluor
GroupPolyclonals and antibodies
About The advantage is that there are more epitopes available in a polyclonal antiserum to detect the proteins than in monoclonal sera, immunohistochemistry on frozen slices or parrafin fixed tissues, Polyclonals can be used for Western blot
Gene targetGPR102/TAAR8
Short nameAnti-GPR102/TAAR8 (Polyclonal) Fluor 594
Technique Pabs are a collection of immunoglobulin , Polyclonal antibodies , each identifying a different , whereas , (pAbs) are mostly rabbit or goat , B cells, Polyclonal, antibodies , antigen, come from a single N cell lineage, epitope, molecules that react against a specific , monoclonal antibodies , that are secreted by different 
LabelALEXA
Alternative name ALEXA Fluor 594, antibody to-GPR102/TAAR8 (polyclonal)
Alternative techniquepolyclonals
Identity 14964
Gene TAAR8
Long gene name trace amine associated receptor 8
Synonyms gene GPR102 TRAR5
Synonyms gene name trace amine receptor 5
Locus 6q23, 2
Discovery year 2001-04-23
GenBank acession AF380193
Entrez gene record 83551
Pubmed identfication 11574155 15718104
RefSeq identity NM_053278
Classification Trace amine receptors
Havana BLAST/BLAT OTTHUMG00000015586

Similar products

Subscribe to our Newsletter